Cervical cancer: a preventable death
- PMID: 20111660
- PMCID: PMC2812875
Cervical cancer: a preventable death
Abstract
Cervical cancer kills 260,000 women annually, and nearly 85% of these deaths occur in developing nations, where it is the leading cause of cancer deaths in women. Disparities of health and poverty play a large role in this high mortality rate. Whereas routine Papanicolaou and human papillomavirus (HPV) testing has dramatically reduced cervical cancer deaths in Western nations, without proper infrastructure, facilities, and medical training, the rates of cervical cancer in developing nations will remain high. Studies on HPV DNA testing and the low-technology method of "screen and treat" are promising. In addition, reducing the cost and increasing the availability of HPV vaccines in developing nations brings hope and promise to the next generation of women.
Keywords: Cervical cancer; Human papillomavirus; Human papillomavirus DNA testing; Human papillomavirus vaccine.
Figures


References
-
- The Nobel Prize in Physiology or Medicine 2008 [press release] Stockholm, Sweden: The Nobel Assembly at Karolinska Institutet; 2008. Oct 6, [Accessed November 20, 2009]. http://nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html.
-
- World Health Organization, authors. Weekly Epidemiological Record. Geneva;: World Health Organization; 2009. [Accessed November 20, 2009]. Human papillomavirus vaccines. http://www.who.int/wer/2009/wer8415.pdf.
-
- Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group (JCCCPG), authors Safety, acceptability, and feasibility of a singlevisit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet. 2003;361:814–820. - PubMed
-
- Sankaranarayanan R, Nene BM, Dinshaw KA, et al. Osmanabad District Cervical Screening Study Group, authors. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005;116:617–623. - PubMed
-
- Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Alliance for Cervical Cancer Prevention Cost Working Group, authors. Cost-effectiveness of cervicalcancer screening in five developing countries. N Engl J Med. 2005;353:2158–2168. - PubMed
LinkOut - more resources
Full Text Sources